Análisis Argos
EHC
EHCCara
Encompass Health Corporation · Healthcare
US$ 116.03
precio al 2026-07-28
Valor justo Argos*
US$ 44–55
vs. su valor justo
134% por encima
Score Argos
76/100
LA RESPUESTA
El mercado le pide crezca 28.6% al año — más de lo que ha demostrado (8.4%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
Cotiza 24% por debajo de su valor justo.
Las ganancias crecieron 24% el último año.
Retorno sobre el capital alto (17%).
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
VALOR1/6FUTURO3/6PASADO5/6SALUD3/6DIVIDENDO3/6
El Iris de calidad
VALOR1/6FUTURO3/6PASADO5/6SALUD3/6DIVIDENDO3/6
ValorCotiza por encima de su valor justo
FuturoCrecimiento moderado
PasadoFundamentales sólidos y sostenidos
SaludBalance razonable
DividendoRetorno al accionista moderado
Score Argos76de 100Cara
Ingresos11%
US$ 5.9 B
Margen operativo10%
17.7%
Flujo de caja libre22%
US$ 0.4 B
Deuda neta
US$ 2.6 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 11.5B
P/E20.3x
EV/EBITDA10.2x
FCF yield3.8%
ROIC16.6%
Margen operativo17.7%
Crecim. ingresos+10.5%/año
Piotroski F8/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

defenseworld.net · 26 jul
Dimensional Fund Advisors LP Grows Position in Encompass Health Corporation $EHC
Dimensional Fund Advisors LP grew its position in shares of Encompass Health Corporation (NYSE: EHC) by 3.1% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,674,784 shares of the company's stock after purchasing an additional 50,647 shares
prnewswire.com · 23 jul
Encompass Health increases and declares dividend on common stock
BIRMINGHAM, Ala., July 23, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced that its board of directors approved an increase of $0.02 in the Company's quarterly dividend and declared a quarterly cash dividend on its common stock of $0.21 per share, payable on Oct. 15, 2026, to holders of record on Oct. 1, 2026.
prnewswire.com · 9 jul
Encompass Health announces date of 2026 second quarter earnings call
BIRMINGHAM, Ala., July 9, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its second quarter ended June 30, 2026, after the market closes on Wednesday, Aug. 5, 2026.
zacks.com · 30 jun
Here's Why Encompass Health (EHC) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zacks.com · 29 jun
Can Encompass Health's Expansion Strategy Drive Its Next Growth Phase?
EHC is accelerating hospital and bed expansions to boost capacity, with execution now key as stronger results support higher 2026 EPS guidance.
zacks.com · 23 jun
Encompass Health (EHC) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
fool.com · 15 jun
DaVita vs. Encompass Health: Which Healthcare Stock Is a Better Buy in 2026?
DaVita operates more than 3,200 dialysis centers globally, serving roughly 295,000 patients with a dominant market share in kidney care. Encompass Health is a leader in inpatient rehabilitation with double-digit revenue growth and higher net margins than its peer in this matchup.
marketbeat.com · 15 jun
Healthcare Added 35,200 Jobs—3 Stocks Positioned to Benefit
The May Jobs report told a familiar story for investors in healthcare stocks. The sector added 35,200 positions last month, led by ambulatory health services at 25,700 and hospitals at 6,000.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.